Pharmaceutical Evaluation & Policy

Pharmaceuticals are increasingly being used to cure, treat, manage, or provide relief for many human afflictions, however, issues of financing, efficiency, access, adherence, and safety of pharmaceuticals continue to challenge the health care systems of the world. The Pharmaceutical Sciences M.S. and Ph.D. programs offer a Pharmaceutical Evaluation and Policy (PEP) track to meet the training needs of persons with business, science, and health care backgrounds wishing to contribute to the understanding of the value, safety, outcomes of pharmaceuticals and pharmaceutical policies.

PEP works closely with state, national, and international  leaders to help guide policy evaluation and development as well as to develop scientific guidances and to conduct rigorous original research.  Our program utilizes an applied approach where graduate trainees gain strong analytic skills that have applications in Pharmacoeconomics, Comparative Effectiveness Research, Epidemiology, and Policy Analysis preparing graduates for careers in industry based health economics and outcomes research (HEOR) careers where persons communicate value propositions for pharmaceutical based technologies and careers in academia and government.


For more information contact:

Dr. Bradley Martin, PharmD, PhD